ADPTAdaptive Biotechnologies Corp
- Market cap
- $4.07B
- as of 2026-10-23
- Latest close
- $25.51
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Diagnostics & Research
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-20
Dashed line = amended filing (Form 4/A)
Showing the latest 500 of 538 transactions.
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Rubinstein JuliePresident and COO | Oct 21 | Oct 21 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 21 | Oct 21 | S | 5,999 | $25.25 | Sale −$151,475 | 383,684 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 21 | Oct 21 | S | 5,882 | $25.57 | Sale −$150,403 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 21 | Oct 21 | M · derivative | 11,881 | $12.14 | $144,235 | 201,562 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 20 | Oct 21 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 20 | Oct 21 | S | 11,781 | $24.53 | Sale −$288,988 | 377,902 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 20 | Oct 21 | S | 100 | $24.85 | Sale −$2,485 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 20 | Oct 21 | M · derivative | 11,881 | $12.14 | $144,235 | 213,443 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 19 | Oct 21 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 19 | Oct 21 | S | 11,881 | $24.05 | Sale −$285,738 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 19 | Oct 21 | M · derivative | 11,881 | $12.14 | $144,235 | 225,324 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 16 | Oct 16 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 16 | Oct 16 | S | 11,581 | $24.21 | Sale −$280,376 | 378,102 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 16 | Oct 16 | S | 300 | $25.45 | Sale −$7,635 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 16 | Oct 16 | M · derivative | 11,881 | $12.14 | $144,235 | 237,205 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 15 | Oct 16 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 15 | Oct 16 | S | 11,881 | $25.61 | Sale −$304,272 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 15 | Oct 16 | M · derivative | 11,881 | $12.14 | $144,235 | 249,086 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 14 | Oct 16 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 14 | Oct 16 | S | 6,781 | $25.57 | Sale −$173,390 | 382,902 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 14 | Oct 16 | S | 5,100 | $25.82 | Sale −$131,682 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 14 | Oct 16 | M · derivative | 11,881 | $12.14 | $144,235 | 260,967 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 13 | Oct 13 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 13 | Oct 13 | S | 11,881 | $25.50 | Sale −$302,966 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 13 | Oct 13 | M · derivative | 11,881 | $12.14 | $144,235 | 272,848 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 12 | Oct 13 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 12 | Oct 13 | S | 9,181 | $25.35 | Sale −$232,738 | 380,502 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 12 | Oct 13 | S | 2,700 | $26.07 | Sale −$70,389 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 12 | Oct 13 | M · derivative | 11,881 | $12.14 | $144,235 | 284,729 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 9 | Oct 13 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 9 | Oct 13 | S | 11,881 | $26.41 | Sale −$313,777 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 9 | Oct 13 | M · derivative | 11,881 | $12.14 | $144,235 | 296,610 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 8 | Oct 8 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 8 | Oct 8 | S | 11,881 | $25.66 | Sale −$304,866 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 8 | Oct 8 | M · derivative | 11,881 | $12.14 | $144,235 | 308,491 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 7 | Oct 8 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 7 | Oct 8 | S | 11,881 | $26.40 | Sale −$313,658 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 7 | Oct 8 | M · derivative | 11,881 | $12.14 | $144,235 | 320,372 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 6 | Oct 8 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 6 | Oct 8 | S | 9,381 | $27.36 | Sale −$256,664 | 380,302 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 6 | Oct 8 | S | 1,100 | $28.21 | Sale −$31,031 | 379,202 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 6 | Oct 8 | S | 901 | $29.71 | Sale −$26,769 | 378,301 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 6 | Oct 8 | S | 499 | $30.53 | Sale −$15,234 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 6 | Oct 8 | M · derivative | 11,881 | $12.14 | $144,235 | 332,253 | Yes | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Oct 6 | Oct 8 | S | 6,444 | $30.00 | Sale −$193,320 | 389,350 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 5 | Oct 5 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 5 | Oct 5 | S | 6,699 | $28.82 | Sale −$193,065 | 382,984 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 5 | Oct 5 | S | 5,182 | $29.67 | Sale −$153,750 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 5 | Oct 5 | M · derivative | 11,881 | $12.14 | $144,235 | 344,134 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 2 | Oct 5 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 2 | Oct 5 | S | 11,881 | $28.13 | Sale −$334,213 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 2 | Oct 5 | M · derivative | 11,881 | $12.14 | $144,235 | 356,015 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 1 | Oct 5 | M | 11,881 | $12.14 | $144,235 | 389,683 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 1 | Oct 5 | S | 6,081 | $27.57 | Sale −$167,653 | 383,602 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 1 | Oct 5 | S | 5,800 | $28.56 | Sale −$165,648 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Oct 1 | Oct 5 | M · derivative | 11,881 | $12.14 | $144,235 | 367,896 | Yes | Form 4 |
| Lo FrancisChief People Officer | Oct 1 | Oct 5 | M | 8,038 | $8.46 | $68,001 | 228,905 | Yes | Form 4 |
| Lo FrancisChief People Officer | Oct 1 | Oct 5 | M | 9,377 | $3.99 | $37,414 | 238,282 | Yes | Form 4 |
| Lo FrancisChief People Officer | Oct 1 | Oct 5 | M | 9,377 | $8.12 | $76,141 | 247,659 | Yes | Form 4 |
| Lo FrancisChief People Officer | Oct 1 | Oct 5 | S | 8,094 | $27.52 | Sale −$222,747 | 239,565 | Yes | Form 4 |
| Lo FrancisChief People Officer | Oct 1 | Oct 5 | S | 18,698 | $28.61 | Sale −$534,950 | 220,867 | Yes | Form 4 |
| Lo FrancisChief People Officer | Oct 1 | Oct 5 | M · derivative | 8,038 | $8.46 | $68,001 | 16,075 | Yes | Form 4 |
| Lo FrancisChief People Officer | Oct 1 | Oct 5 | M · derivative | 9,377 | $3.99 | $37,414 | 56,259 | Yes | Form 4 |
| Lo FrancisChief People Officer | Oct 1 | Oct 5 | M · derivative | 9,377 | $8.12 | $76,141 | 93,765 | Yes | Form 4 |
| Lo FrancisChief People Officer | Sep 16 | Sep 18 | M | 53,091 | $12.14 | $644,525 | 283,804 | Yes | Form 4 |
| Lo FrancisChief People Officer | Sep 16 | Sep 18 | M | 13,398 | $8.46 | $113,347 | 297,202 | Yes | Form 4 |
| Lo FrancisChief People Officer | Sep 16 | Sep 18 | M | 15,629 | $3.99 | $62,360 | 312,831 | Yes | Form 4 |
| Lo FrancisChief People Officer | Sep 16 | Sep 18 | M | 23,442 | $8.12 | $190,349 | 336,273 | Yes | Form 4 |
| Lo FrancisChief People Officer | Sep 16 | Sep 18 | S | 107,537 | $28.02 | Sale −$3,013,187 | 228,736 | Yes | Form 4 |
| Lo FrancisChief People Officer | Sep 16 | Sep 18 | S | 7,869 | $28.57 | Sale −$224,817 | 220,867 | Yes | Form 4 |
| Lo FrancisChief People Officer | Sep 16 | Sep 18 | M · derivative | 53,091 | $12.14 | $644,525 | 79,155 | Yes | Form 4 |
| Lo FrancisChief People Officer | Sep 16 | Sep 18 | M · derivative | 13,398 | $8.46 | $113,347 | 24,113 | Yes | Form 4 |
| Lo FrancisChief People Officer | Sep 16 | Sep 18 | M · derivative | 15,629 | $3.99 | $62,360 | 65,636 | Yes | Form 4 |
| Lo FrancisChief People Officer | Sep 16 | Sep 18 | M · derivative | 23,442 | $8.12 | $190,349 | 103,142 | Yes | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Sep 15 | Sep 17 | S | 1,195 | $27.00 | Sale −$32,265 | 395,794 | Yes | Form 4 |
| Owen Katey Einterz | Aug 31 | Sep 2 | G | 12,539 | not reported | not reported | 66,100 | No | Form 4 |
| Owen Katey Einterz | Aug 26 | Aug 28 | S | 9,615 | $26.00 | Sale −$249,990 | 78,639 | No | Form 4 |
| Hershberg Robert | Aug 18 | Aug 20 | M | 15,000 | $6.32 | $94,800 | 77,347 | No | Form 4 |
| Hershberg Robert | Aug 18 | Aug 20 | S | 15,000 | $24.39 | Sale −$365,850 | 62,347 | No | Form 4 |
| Hershberg Robert | Aug 18 | Aug 20 | S | 15,664 | $24.41 | Sale −$382,358 | 46,683 | No | Form 4 |
| Hershberg Robert | Aug 18 | Aug 20 | M · derivative | 15,000 | $6.32 | $94,800 | not reported | No | Form 4 |
| Robins Chad MCEO and Chairman | Aug 18 | Aug 19 | M | 278,676 | $6.55 | $1,825,328 | 2,459,194 | No | Form 4 |
| Robins Chad MCEO and Chairman | Aug 18 | Aug 19 | S | 278,472 | $24.48 | Sale −$6,816,995 | 2,180,722 | No | Form 4 |
| Robins Chad MCEO and Chairman | Aug 18 | Aug 19 | S | 204 | $25.14 | Sale −$5,129 | 2,180,518 | No | Form 4 |
| Robins Chad MCEO and Chairman | Aug 18 | Aug 19 | M · derivative | 278,676 | $6.55 | $1,825,328 | not reported | No | Form 4 |
| Neupert Peter M | Aug 17 | Aug 19 | M | 15,000 | $6.32 | $94,800 | 255,315 | No | Form 4 |
| Neupert Peter M | Aug 17 | Aug 19 | S | 15,000 | $25.23 | Sale −$378,450 | 240,315 | No | Form 4 |
| Neupert Peter M | Aug 17 | Aug 19 | S | 40,000 | $25.10 | Sale −$1,004,000 | 200,315 | No | Form 4 |
| Neupert Peter M | Aug 17 | Aug 19 | S | 69,690 | $25.16 | Sale −$1,753,400 | 130,625 | No | Form 4 |
| Neupert Peter M | Aug 17 | Aug 19 | M · derivative | 15,000 | $6.32 | $94,800 | not reported | No | Form 4 |
| Robins Chad MCEO and Chairman | Aug 17 | Aug 19 | M | 321,324 | $6.55 | $2,104,672 | 2,501,842 | No | Form 4 |
| Robins Chad MCEO and Chairman | Aug 17 | Aug 19 | S | 318,799 | $25.08 | Sale −$7,995,479 | 2,183,043 | No | Form 4 |
| Robins Chad MCEO and Chairman | Aug 17 | Aug 19 | S | 2,525 | $25.57 | Sale −$64,564 | 2,180,518 | No | Form 4 |
| Robins Chad MCEO and Chairman | Aug 17 | Aug 19 | M · derivative | 321,324 | $6.55 | $2,104,672 | 278,676 | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Aug 10 | Aug 12 | S | 3,000 | $25.00 | Sale −$75,000 | 396,989 | Yes | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Jul 30 | Aug 3 | S | 1,299 | $24.00 | Sale −$31,176 | 399,989 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Jul 21 | Jul 23 | M | 284,800 | $6.55 | $1,865,440 | 1,304,458 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Jul 21 | Jul 23 | S | 278,698 | $21.72 | Sale −$6,053,321 | 1,025,760 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Jul 21 | Jul 23 | S | 213,702 | $22.12 | Sale −$4,727,088 | 812,058 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Jul 21 | Jul 23 | M · derivative | 284,800 | $6.55 | $1,865,440 | not reported | Yes | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Jul 16 | Jul 20 | S | 5,000 | $23.00 | Sale −$115,000 | 401,288 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 15 | Jul 17 | M | 59,374 | $7.80 | $463,117 | 290,087 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 15 | Jul 17 | M | 23,677 | $12.14 | $287,439 | 313,764 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 15 | Jul 17 | M | 22,711 | $8.46 | $192,135 | 336,475 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 15 | Jul 17 | S | 105,762 | $22.59 | Sale −$2,389,164 | 230,713 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 15 | Jul 17 | M · derivative | 59,374 | $7.80 | $463,117 | not reported | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 15 | Jul 17 | M · derivative | 23,677 | $12.14 | $287,439 | 132,246 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 15 | Jul 17 | M · derivative | 22,711 | $8.46 | $192,135 | 37,511 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Jul 2 | Jul 7 | S | 239,351 | $21.74 | Sale −$5,203,491 | 1,166,547 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Jul 2 | Jul 7 | S | 146,889 | $22.45 | Sale −$3,297,658 | 1,019,658 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 2 | Jul 6 | M | 12,626 | $7.80 | $98,483 | 250,314 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 2 | Jul 6 | M | 12,600 | $12.14 | $152,964 | 262,914 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 2 | Jul 6 | M | 12,637 | $8.46 | $106,909 | 275,551 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 2 | Jul 6 | S | 44,838 | $22.59 | Sale −$1,012,890 | 230,713 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 2 | Jul 6 | M · derivative | 12,626 | $7.80 | $98,483 | 59,374 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 2 | Jul 6 | M · derivative | 12,600 | $12.14 | $152,964 | 155,923 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 2 | Jul 6 | M · derivative | 12,637 | $8.46 | $106,909 | 60,222 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | M | 3,500 | $7.80 | $27,300 | 254,434 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | M | 3,300 | $12.14 | $40,062 | 257,734 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | M | 12,206 | $8.46 | $103,263 | 269,940 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | M | 4,688 | $3.99 | $18,705 | 274,628 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | M | 14,064 | $8.12 | $114,200 | 288,692 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | S | 8,743 | $22.18 | Sale −$193,920 | 279,949 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | S | 42,261 | $22.50 | Sale −$950,873 | 237,688 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | M · derivative | 3,500 | $7.80 | $27,300 | 72,000 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | M · derivative | 3,300 | $12.14 | $40,062 | 168,523 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | M · derivative | 12,206 | $8.46 | $103,263 | 72,859 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | M · derivative | 4,688 | $3.99 | $18,705 | 81,265 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jul 1 | Jul 6 | M · derivative | 14,064 | $8.12 | $114,200 | 126,584 | Yes | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Jul 1 | Jul 6 | S | 487 | $22.00 | Sale −$10,714 | 406,288 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 29 | Jun 30 | M | 1,837 | $12.14 | $22,301 | 274,588 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 29 | Jun 30 | M | 24,944 | $8.46 | $211,026 | 299,532 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 29 | Jun 30 | M | 24,944 | $3.99 | $99,527 | 324,476 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 29 | Jun 30 | M | 51,570 | $8.12 | $418,748 | 376,046 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 29 | Jun 30 | S | 154,768 | $21.14 | Sale −$3,271,796 | 221,278 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 29 | Jun 30 | M · derivative | 1,837 | $12.14 | $22,301 | not reported | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 29 | Jun 30 | M · derivative | 24,944 | $8.46 | $211,026 | 37,416 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 29 | Jun 30 | M · derivative | 24,944 | $3.99 | $99,527 | 87,303 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 29 | Jun 30 | M · derivative | 51,570 | $8.12 | $418,748 | 113,457 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 26 | Jun 30 | M | 11,034 | $12.14 | $133,953 | 283,785 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 26 | Jun 30 | S | 11,034 | $21.00 | Sale −$231,714 | 272,751 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Jun 26 | Jun 30 | M · derivative | 11,034 | $12.14 | $133,953 | 1,837 | Yes | Form 4 |
| Griffin Michelle Renee | Jun 25 | Jun 29 | M | 52,084 | $7.80 | $406,255 | 67,709 | Yes | Form 4 |
| Griffin Michelle Renee | Jun 25 | Jun 29 | S | 52,084 | $20.18 | Sale −$1,051,055 | 15,625 | Yes | Form 4 |
| Griffin Michelle Renee | Jun 25 | Jun 29 | M · derivative | 52,084 | $7.80 | $406,255 | not reported | Yes | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Jun 25 | Jun 29 | S | 5,000 | $20.50 | Sale −$102,500 | 406,775 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Jun 16 | Jun 17 | S | 6,160 | $18.01 | Sale −$110,942 | 1,405,898 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Jun 15 | Jun 17 | S | 100,000 | $17.37 | Sale −$1,737,000 | 1,412,058 | Yes | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Jun 11 | Jun 15 | S | 5,000 | $19.00 | Sale −$95,000 | 411,775 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jun 4 | Jun 8 | M | 5,792 | $12.14 | $70,315 | 276,946 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jun 4 | Jun 8 | M | 2,009 | $8.46 | $16,996 | 278,955 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jun 4 | Jun 8 | M | 2,344 | $3.99 | $9,353 | 281,299 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jun 4 | Jun 8 | M | 9,376 | $8.12 | $76,133 | 290,675 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jun 4 | Jun 8 | S | 39,741 | $17.49 | Sale −$695,070 | 250,934 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jun 4 | Jun 8 | M · derivative | 5,792 | $12.14 | $70,315 | 171,823 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jun 4 | Jun 8 | M · derivative | 2,009 | $8.46 | $16,996 | 85,065 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jun 4 | Jun 8 | M · derivative | 2,344 | $3.99 | $9,353 | 85,953 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jun 4 | Jun 8 | M · derivative | 9,376 | $8.12 | $76,133 | 140,648 | Yes | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Jun 4 | Jun 8 | S | 11,000 | $18.00 | Sale −$198,000 | 416,775 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | May 18 | May 20 | S | 3,115 | $13.04 | Sale −$40,620 | 256,725 | No | Form 4 |
| Rubinstein JuliePresident and COO | Apr 27 | Apr 29 | M | 14,707 | $8.46 | $124,421 | 396,839 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 27 | Apr 29 | S | 19,037 | $14.23 | Sale −$270,897 | 377,802 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 27 | Apr 29 | M · derivative | 14,707 | $8.46 | $124,421 | 45,731 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 24 | Apr 24 | M | 14,722 | $8.46 | $124,548 | 401,192 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 24 | Apr 24 | S | 19,060 | $14.02 | Sale −$267,221 | 382,132 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 24 | Apr 24 | M · derivative | 14,722 | $8.46 | $124,548 | 60,438 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 23 | Apr 24 | M | 14,722 | $8.46 | $124,548 | 405,530 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 23 | Apr 24 | S | 19,060 | $13.74 | Sale −$261,884 | 386,470 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 23 | Apr 24 | M · derivative | 14,722 | $8.46 | $124,548 | 75,160 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 22 | Apr 24 | M | 14,722 | $8.46 | $124,548 | 409,868 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 22 | Apr 24 | S | 19,060 | $14.13 | Sale −$269,318 | 390,808 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 22 | Apr 24 | M · derivative | 14,722 | $8.46 | $124,548 | 89,882 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 21 | Apr 21 | M | 14,722 | $8.46 | $124,548 | 414,206 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 21 | Apr 21 | M | 11,881 | $12.14 | $144,235 | 426,087 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 21 | Apr 21 | S | 30,941 | $14.66 | Sale −$453,595 | 395,146 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 21 | Apr 21 | M · derivative | 14,722 | $8.46 | $124,548 | 104,604 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 21 | Apr 21 | M · derivative | 11,881 | $12.14 | $144,235 | 379,777 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 20 | Apr 21 | M | 14,722 | $8.46 | $124,548 | 418,544 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 20 | Apr 21 | S | 19,060 | $14.55 | Sale −$277,323 | 399,484 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 20 | Apr 21 | M · derivative | 14,722 | $8.46 | $124,548 | 119,326 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 17 | Apr 21 | M | 14,722 | $8.46 | $124,548 | 422,882 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 17 | Apr 21 | S | 19,060 | $14.57 | Sale −$277,704 | 403,822 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 17 | Apr 21 | M · derivative | 14,722 | $8.46 | $124,548 | 134,048 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 16 | Apr 16 | M | 14,722 | $8.46 | $124,548 | 427,220 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 16 | Apr 16 | S | 19,060 | $14.18 | Sale −$270,271 | 408,160 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 16 | Apr 16 | M · derivative | 14,722 | $8.46 | $124,548 | 148,770 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 15 | Apr 16 | M | 14,722 | $8.46 | $124,548 | 431,558 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 15 | Apr 16 | S | 19,060 | $14.61 | Sale −$278,467 | 412,498 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 15 | Apr 16 | M · derivative | 14,722 | $8.46 | $124,548 | 163,492 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 14 | Apr 16 | M | 14,722 | $8.46 | $124,548 | 435,896 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 14 | Apr 16 | S | 19,060 | $14.56 | Sale −$277,514 | 416,836 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 14 | Apr 16 | M · derivative | 14,722 | $8.46 | $124,548 | 178,214 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 13 | Apr 13 | M | 8,109 | $7.27 | $58,952 | 433,621 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 13 | Apr 13 | M | 6,613 | $8.46 | $55,946 | 440,234 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 13 | Apr 13 | S | 15,722 | $12.95 | Sale −$203,600 | 424,512 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 13 | Apr 13 | S | 3,338 | $14.08 | Sale −$46,999 | 421,174 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 13 | Apr 13 | M · derivative | 8,109 | $7.27 | $58,952 | not reported | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 13 | Apr 13 | M · derivative | 6,613 | $8.46 | $55,946 | 192,936 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 10 | Apr 13 | M | 14,722 | $7.27 | $107,029 | 444,572 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 10 | Apr 13 | S | 18,660 | $12.75 | Sale −$237,915 | 425,912 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 10 | Apr 13 | S | 400 | $13.48 | Sale −$5,392 | 425,512 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 10 | Apr 13 | M · derivative | 14,722 | $7.27 | $107,029 | 8,109 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 9 | Apr 13 | M | 14,722 | $7.27 | $107,029 | 448,910 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 9 | Apr 13 | S | 16,960 | $13.79 | Sale −$233,878 | 431,950 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 9 | Apr 13 | S | 2,100 | $14.44 | Sale −$30,324 | 429,850 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 9 | Apr 13 | M · derivative | 14,722 | $7.27 | $107,029 | 22,831 | Yes | Form 4 |
| Lo FrancisChief People Officer | Apr 8 | Apr 10 | M | 2,344 | $3.99 | $9,353 | 293,718 | Yes | Form 4 |
| Lo FrancisChief People Officer | Apr 8 | Apr 10 | S | 22,564 | $15.07 | Sale −$340,039 | 271,154 | Yes | Form 4 |
| Lo FrancisChief People Officer | Apr 8 | Apr 10 | M · derivative | 2,344 | $3.99 | $9,353 | 88,297 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Apr 8 | Apr 10 | S | 10,000 | $14.85 | Sale −$148,500 | 1,512,058 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Apr 8 | Apr 8 | S | 37,263 | $15.19 | Sale −$566,025 | 2,180,518 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 8 | Apr 8 | M | 14,722 | $7.27 | $107,029 | 453,248 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 8 | Apr 8 | M | 11,881 | $12.14 | $144,235 | 465,129 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 8 | Apr 8 | S | 30,841 | $14.83 | Sale −$457,372 | 434,288 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 8 | Apr 8 | S | 100 | $15.48 | Sale −$1,548 | 434,188 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 8 | Apr 8 | M · derivative | 14,722 | $7.27 | $107,029 | 37,553 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 8 | Apr 8 | M · derivative | 11,881 | $12.14 | $144,235 | 391,658 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 7 | Apr 8 | M | 14,722 | $7.27 | $107,029 | 457,586 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 7 | Apr 8 | S | 19,060 | $13.56 | Sale −$258,454 | 438,526 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 7 | Apr 8 | M · derivative | 14,722 | $7.27 | $107,029 | 52,275 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Apr 6 | Apr 8 | S | 83,332 | $14.41 | Sale −$1,200,814 | 2,217,781 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 6 | Apr 8 | M | 14,722 | $7.27 | $107,029 | 461,924 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 6 | Apr 8 | S | 19,060 | $14.33 | Sale −$273,130 | 442,864 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 6 | Apr 8 | M · derivative | 14,722 | $7.27 | $107,029 | 66,997 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 2 | Apr 2 | M | 14,722 | $7.27 | $107,029 | 466,262 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 2 | Apr 2 | S | 19,060 | $14.60 | Sale −$278,276 | 447,202 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 2 | Apr 2 | M · derivative | 14,722 | $7.27 | $107,029 | 81,719 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 1 | Apr 2 | M | 14,722 | $7.27 | $107,029 | 470,600 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 1 | Apr 2 | S | 19,060 | $14.45 | Sale −$275,417 | 451,540 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Apr 1 | Apr 2 | M · derivative | 14,722 | $7.27 | $107,029 | 96,441 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 31 | Mar 31 | M | 14,722 | $7.27 | $107,029 | 474,938 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 31 | Mar 31 | S | 19,060 | $13.45 | Sale −$256,357 | 455,878 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 31 | Mar 31 | M · derivative | 14,722 | $7.27 | $107,029 | 111,163 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 30 | Mar 31 | M | 14,722 | $7.27 | $107,029 | 479,276 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 30 | Mar 31 | S | 19,060 | $12.63 | Sale −$240,728 | 460,216 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 30 | Mar 31 | M · derivative | 14,722 | $7.27 | $107,029 | 125,885 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 27 | Mar 31 | M | 14,722 | $7.27 | $107,029 | 483,614 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 27 | Mar 31 | S | 2,738 | $12.49 | Sale −$34,198 | 480,876 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 27 | Mar 31 | S | 16,322 | $13.48 | Sale −$220,021 | 464,554 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 27 | Mar 31 | M · derivative | 14,722 | $7.27 | $107,029 | 140,607 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 26 | Mar 26 | M | 14,722 | $7.27 | $107,029 | 487,952 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 26 | Mar 26 | S | 19,060 | $14.12 | Sale −$269,127 | 468,892 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 26 | Mar 26 | M · derivative | 14,722 | $7.27 | $107,029 | 155,329 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 25 | Mar 26 | M | 14,722 | $7.27 | $107,029 | 492,290 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 25 | Mar 26 | S | 19,060 | $14.27 | Sale −$271,986 | 473,230 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 25 | Mar 26 | M · derivative | 14,722 | $7.27 | $107,029 | 170,051 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 24 | Mar 26 | M | 14,722 | $7.27 | $107,029 | 496,628 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 24 | Mar 26 | S | 19,060 | $13.70 | Sale −$261,122 | 477,568 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 24 | Mar 26 | M · derivative | 14,722 | $7.27 | $107,029 | 184,773 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 23 | Mar 23 | M | 14,722 | $7.27 | $107,029 | 500,966 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 23 | Mar 23 | S | 19,060 | $13.83 | Sale −$263,600 | 481,906 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 23 | Mar 23 | M · derivative | 14,722 | $7.27 | $107,029 | 199,495 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 20 | Mar 23 | M | 3,939 | $6.55 | $25,800 | 494,521 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 20 | Mar 23 | M | 10,783 | $7.27 | $78,392 | 505,304 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 20 | Mar 23 | S | 19,060 | $13.37 | Sale −$254,832 | 486,244 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 20 | Mar 23 | M · derivative | 3,939 | $6.55 | $25,800 | not reported | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 20 | Mar 23 | M · derivative | 10,783 | $7.27 | $78,392 | 214,217 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 19 | Mar 23 | M | 14,722 | $6.55 | $96,429 | 509,642 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 19 | Mar 23 | S | 19,060 | $13.18 | Sale −$251,211 | 490,582 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 19 | Mar 23 | M · derivative | 14,722 | $6.55 | $96,429 | 3,939 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 18 | Mar 18 | M | 14,722 | $6.55 | $96,429 | 513,980 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 18 | Mar 18 | S | 19,060 | $13.18 | Sale −$251,211 | 494,920 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 18 | Mar 18 | M · derivative | 14,722 | $6.55 | $96,429 | 18,661 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 17 | Mar 18 | M | 14,722 | $6.55 | $96,429 | 518,318 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 17 | Mar 18 | S | 19,060 | $13.40 | Sale −$255,404 | 499,258 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 17 | Mar 18 | M · derivative | 14,722 | $6.55 | $96,429 | 33,383 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 16 | Mar 18 | M | 14,722 | $6.55 | $96,429 | 522,656 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 16 | Mar 18 | S | 19,060 | $13.41 | Sale −$255,595 | 503,596 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 16 | Mar 18 | M · derivative | 14,722 | $6.55 | $96,429 | 48,105 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 13 | Mar 13 | M | 14,722 | $6.55 | $96,429 | 526,994 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 13 | Mar 13 | S | 19,060 | $12.96 | Sale −$247,018 | 507,934 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 13 | Mar 13 | M · derivative | 14,722 | $6.55 | $96,429 | 62,827 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 12 | Mar 13 | M | 14,722 | $6.55 | $96,429 | 531,332 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 12 | Mar 13 | S | 13,660 | $12.63 | Sale −$172,526 | 517,672 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 12 | Mar 13 | S | 5,400 | $13.43 | Sale −$72,522 | 512,272 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 12 | Mar 13 | M · derivative | 14,722 | $6.55 | $96,429 | 77,549 | Yes | Form 4 |
| Griffin Michelle Renee | Mar 11 | Mar 13 | S | 15,394 | $13.91 | Sale −$214,131 | 15,625 | No | Form 4 |
| Robins Chad MCEO and Chairman | Mar 11 | Mar 13 | S | 140,567 | $13.17 | Sale −$1,851,267 | 2,630,713 | No | Form 4 |
| Robins Chad MCEO and Chairman | Mar 11 | Mar 13 | S | 329,600 | $13.17 | Sale −$4,340,832 | 2,301,113 | No | Form 4 |
| Lo FrancisChief People Officer | Mar 11 | Mar 13 | S | 30,593 | $14.08 | Sale −$430,749 | 291,374 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Mar 11 | Mar 13 | S | 18,672 | $13.17 | Sale −$245,910 | 259,840 | No | Form 4 |
| Rubinstein JuliePresident and COO | Mar 11 | Mar 13 | S | 122,523 | $13.17 | Sale −$1,613,628 | 520,948 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 11 | Mar 13 | M | 14,722 | $6.55 | $96,429 | 535,670 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 11 | Mar 13 | S | 19,060 | $14.08 | Sale −$268,365 | 516,610 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 11 | Mar 13 | M · derivative | 14,722 | $6.55 | $96,429 | 92,271 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 11 | Mar 13 | S | 140,666 | $13.17 | Sale −$1,852,571 | 1,851,658 | No | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 11 | Mar 13 | S | 329,600 | $13.17 | Sale −$4,340,832 | 1,522,058 | No | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Mar 11 | Mar 13 | S | 63,103 | $13.17 | Sale −$831,067 | 272,751 | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Mar 11 | Mar 13 | S | 41,338 | $13.17 | Sale −$544,421 | 427,775 | No | Form 4 |
| Rubinstein JuliePresident and COO | Mar 10 | Mar 10 | M | 14,722 | $6.55 | $96,429 | 662,531 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 10 | Mar 10 | M | 400 | $12.14 | $4,856 | 662,931 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 10 | Mar 10 | S | 19,460 | $14.68 | Sale −$285,673 | 643,471 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 10 | Mar 10 | M · derivative | 14,722 | $6.55 | $96,429 | 106,993 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 10 | Mar 10 | M · derivative | 400 | $12.14 | $4,856 | 403,539 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 9 | Mar 10 | M | 14,722 | $6.55 | $96,429 | 666,869 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 9 | Mar 10 | M | 11,881 | $12.14 | $144,235 | 678,750 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 9 | Mar 10 | S | 30,941 | $14.79 | Sale −$457,617 | 647,809 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 9 | Mar 10 | M · derivative | 14,722 | $6.55 | $96,429 | 121,715 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 9 | Mar 10 | M · derivative | 11,881 | $12.14 | $144,235 | 403,939 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 6 | Mar 10 | M | 14,722 | $6.55 | $96,429 | 671,207 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 6 | Mar 10 | M | 11,881 | $12.14 | $144,235 | 683,088 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 6 | Mar 10 | S | 30,941 | $15.14 | Sale −$468,447 | 652,147 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 6 | Mar 10 | M · derivative | 14,722 | $6.55 | $96,429 | 136,437 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 6 | Mar 10 | M · derivative | 11,881 | $12.14 | $144,235 | 415,820 | Yes | Form 4 |
| Lo FrancisChief People Officer | Mar 5 | Mar 9 | S | 38,074 | $15.09 | Sale −$574,537 | 321,967 | No | Form 4 |
| Robins Chad MCEO and Chairman | Mar 6 | Mar 6 | A | 709,220 | $0.00 | $0 | 2,771,280 | No | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 6 | Mar 6 | A | 709,220 | $0.00 | $0 | 1,992,324 | No | Form 4 |
| Griffin Michelle Renee | Mar 4 | Mar 6 | A | 15,625 | $0.00 | $0 | 31,019 | No | Form 4 |
| Neupert Peter M | Mar 4 | Mar 6 | A | 15,625 | $0.00 | $0 | 240,315 | No | Form 4 |
| Hershberg Robert | Mar 4 | Mar 6 | A | 15,625 | $0.00 | $0 | 62,347 | No | Form 4 |
| Robins Chad MCEO and Chairman | Mar 4 | Mar 6 | A | 127,813 | $0.00 | $0 | 2,062,060 | No | Form 4 |
| Lo FrancisChief People Officer | Mar 4 | Mar 6 | A | 44,063 | $0.00 | $0 | 360,041 | No | Form 4 |
| Piskel KyleChief Financial Officer | Mar 4 | Mar 6 | A | 61,875 | $0.00 | $0 | 278,512 | No | Form 4 |
| Rubinstein JuliePresident and COO | Mar 4 | Mar 6 | A | 81,250 | $0.00 | $0 | 656,485 | No | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 4 | Mar 6 | A | 127,813 | $0.00 | $0 | 1,283,104 | No | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Mar 4 | Mar 6 | A | 39,063 | $0.00 | $0 | 335,854 | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Mar 4 | Mar 6 | A | 59,375 | $0.00 | $0 | 406,613 | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Mar 4 | Mar 6 | A | 62,500 | $0.00 | $0 | 469,113 | No | Form 4 |
| Owen Katey Einterz | Mar 4 | Mar 6 | A | 15,625 | $0.00 | $0 | 88,254 | No | Form 4 |
| Rubinstein JuliePresident and COO | Mar 5 | Mar 5 | M | 14,722 | $6.55 | $96,429 | 594,295 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 5 | Mar 5 | M | 11,881 | $12.14 | $144,235 | 606,176 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 5 | Mar 5 | S | 30,941 | $16.00 | Sale −$495,056 | 575,235 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 5 | Mar 5 | M · derivative | 14,722 | $6.55 | $96,429 | 151,159 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 5 | Mar 5 | M · derivative | 11,881 | $12.14 | $144,235 | 427,701 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 4 | Mar 5 | M | 14,722 | $6.55 | $96,429 | 598,633 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 4 | Mar 5 | M | 11,881 | $12.14 | $144,235 | 610,514 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 4 | Mar 5 | S | 30,941 | $16.60 | Sale −$513,621 | 579,573 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 4 | Mar 5 | M · derivative | 14,722 | $6.55 | $96,429 | 165,881 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 4 | Mar 5 | M · derivative | 11,881 | $12.14 | $144,235 | 439,582 | Yes | Form 4 |
| Griffin Michelle Renee | Mar 3 | Mar 5 | M | 48,044 | $3.99 | $191,696 | 63,438 | Yes | Form 4 |
| Griffin Michelle Renee | Mar 3 | Mar 5 | S | 48,044 | $15.30 | Sale −$735,073 | 15,394 | Yes | Form 4 |
| Griffin Michelle Renee | Mar 3 | Mar 5 | M · derivative | 48,044 | $3.99 | $191,696 | not reported | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 3 | Mar 5 | M | 14,722 | $6.55 | $96,429 | 602,971 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 3 | Mar 5 | M | 11,881 | $12.14 | $144,235 | 614,852 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 3 | Mar 5 | S | 24,423 | $15.49 | Sale −$378,312 | 590,429 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 3 | Mar 5 | S | 6,518 | $16.33 | Sale −$106,439 | 583,911 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 3 | Mar 5 | M · derivative | 14,722 | $6.55 | $96,429 | 180,603 | Yes | Form 4 |
| Rubinstein JuliePresident and COO | Mar 3 | Mar 5 | M · derivative | 11,881 | $12.14 | $144,235 | 451,463 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 3 | Mar 4 | S | 14,233 | $16.52 | Sale −$235,129 | 1,155,291 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 2 | Mar 4 | S | 10,000 | $15.72 | Sale −$157,200 | 1,169,524 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Mar 3 | Mar 3 | S | 50,703 | $15.49 | Sale −$785,389 | 1,936,627 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Mar 3 | Mar 3 | S | 2,380 | $16.15 | Sale −$38,437 | 1,934,247 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Mar 2 | Mar 3 | S | 289,024 | $15.82 | Sale −$4,572,360 | 1,987,330 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 27 | Mar 3 | S | 182,891 | $15.99 | Sale −$2,924,427 | 2,276,354 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Feb 4 | Feb 6 | M | 2,145 | $12.14 | $26,040 | 218,782 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Feb 4 | Feb 6 | S | 2,145 | $18.46 | Sale −$39,597 | 216,637 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Feb 4 | Feb 6 | M · derivative | 2,145 | $12.14 | $26,040 | 2,146 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Feb 3 | Feb 4 | S | 8,120 | $19.00 | Sale −$154,280 | 1,179,524 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 2 | Feb 4 | S | 124,998 | $18.44 | Sale −$2,304,963 | 2,459,245 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Feb 2 | Feb 4 | S | 34,668 | $18.60 | Sale −$644,825 | 1,187,644 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 12 | Jan 14 | M | 36,650 | $7.80 | $285,870 | 352,628 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 12 | Jan 14 | M | 7,723 | $12.14 | $93,757 | 360,351 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 12 | Jan 14 | M | 21,002 | $8.46 | $177,677 | 381,353 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 12 | Jan 14 | M | 14,215 | $3.99 | $56,718 | 395,568 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 12 | Jan 14 | S | 79,590 | $17.73 | Sale −$1,411,131 | 315,978 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 12 | Jan 14 | M · derivative | 36,650 | $7.80 | $285,870 | 75,500 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 12 | Jan 14 | M · derivative | 7,723 | $12.14 | $93,757 | 177,615 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 12 | Jan 14 | M · derivative | 21,002 | $8.46 | $177,677 | 87,074 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 12 | Jan 14 | M · derivative | 14,215 | $3.99 | $56,718 | 90,641 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Jan 12 | Jan 14 | M | 4,290 | $12.14 | $52,081 | 220,927 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Jan 12 | Jan 14 | S | 4,290 | $18.00 | Sale −$77,220 | 216,637 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Jan 12 | Jan 14 | M · derivative | 4,290 | $12.14 | $52,081 | 4,291 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Jan 6 | Jan 8 | S | 10,000 | $16.44 | Sale −$164,400 | 1,222,312 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Jan 5 | Jan 7 | S | 124,998 | $15.59 | Sale −$1,948,719 | 2,584,243 | Yes | Form 4 |
| Lo FrancisChief People Officer | Dec 22, 2025 | Jan 74/A | M | 1,100 | $7.80 | $8,580 | 317,078 | Yes | Form 4/A |
| Lo FrancisChief People Officer | Dec 22, 2025 | Jan 74/A | M | 1,100 | $8.46 | $9,306 | 318,178 | Yes | Form 4/A |
| Lo FrancisChief People Officer | Dec 22, 2025 | Jan 74/A | M | 2,194 | $3.99 | $8,754 | 320,372 | Yes | Form 4/A |
| Lo FrancisChief People Officer | Dec 22, 2025 | Jan 74/A | S | 4,394 | $17.50 | Sale −$76,895 | 315,978 | Yes | Form 4/A |
| Lo FrancisChief People Officer | Dec 22, 2025 | Jan 74/A | M · derivative | 1,100 | $7.80 | $8,580 | 112,150 | Yes | Form 4/A |
| Lo FrancisChief People Officer | Dec 22, 2025 | Jan 74/A | M · derivative | 1,100 | $8.46 | $9,306 | 108,076 | Yes | Form 4/A |
| Lo FrancisChief People Officer | Dec 22, 2025 | Jan 74/A | M · derivative | 2,194 | $3.99 | $8,754 | 107,981 | Yes | Form 4/A |
| Lo FrancisChief People Officer | Jan 2 | Jan 6 | M | 3,125 | $3.99 | $12,469 | 319,103 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 2 | Jan 6 | S | 3,125 | $16.08 | Sale −$50,250 | 315,978 | Yes | Form 4 |
| Lo FrancisChief People Officer | Jan 2 | Jan 6 | M · derivative | 3,125 | $3.99 | $12,469 | 104,856 | Yes | Form 4 |
| Lo FrancisChief People Officer | Dec 15, 2025 | Dec 17, 2025 | M | 37,750 | $7.80 | $294,450 | 370,596 | Yes | Form 4 |
| Lo FrancisChief People Officer | Dec 15, 2025 | Dec 17, 2025 | M | 19,423 | $8.46 | $164,319 | 390,019 | Yes | Form 4 |
| Lo FrancisChief People Officer | Dec 15, 2025 | Dec 17, 2025 | M | 39,849 | $3.99 | $158,998 | 429,868 | Yes | Form 4 |
| Lo FrancisChief People Officer | Dec 15, 2025 | Dec 17, 2025 | S | 113,890 | $15.57 | Sale −$1,773,267 | 315,978 | Yes | Form 4 |
| Lo FrancisChief People Officer | Dec 15, 2025 | Dec 17, 2025 | M · derivative | 37,750 | $7.80 | $294,450 | 113,250 | Yes | Form 4 |
| Lo FrancisChief People Officer | Dec 15, 2025 | Dec 17, 2025 | M · derivative | 19,423 | $8.46 | $164,319 | 109,176 | Yes | Form 4 |
| Lo FrancisChief People Officer | Dec 15, 2025 | Dec 17, 2025 | M · derivative | 39,849 | $3.99 | $158,998 | 110,175 | Yes | Form 4 |
| Hershberg Robert | Dec 10, 2025 | Dec 12, 2025 | S | 22,968 | $16.00 | Sale −$367,488 | 46,722 | No | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Dec 4, 2025 | Dec 8, 2025 | M | 4,290 | $12.14 | $52,081 | 301,081 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Dec 4, 2025 | Dec 8, 2025 | M | 4,157 | $8.46 | $35,168 | 305,238 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Dec 4, 2025 | Dec 8, 2025 | M | 4,157 | $3.99 | $16,586 | 309,395 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Dec 4, 2025 | Dec 8, 2025 | S | 12,604 | $16.85 | Sale −$212,377 | 296,791 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Dec 4, 2025 | Dec 8, 2025 | M · derivative | 4,290 | $12.14 | $52,081 | 12,871 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Dec 4, 2025 | Dec 8, 2025 | M · derivative | 4,157 | $8.46 | $35,168 | 62,360 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Dec 4, 2025 | Dec 8, 2025 | M · derivative | 4,157 | $3.99 | $16,586 | 112,247 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Dec 4, 2025 | Dec 5, 2025 | S | 10,000 | $16.61 | Sale −$166,100 | 1,232,312 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Dec 3, 2025 | Dec 5, 2025 | S | 27,212 | $18.61 | Sale −$506,415 | 1,242,312 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Nov 28, 2025 | Dec 2, 2025 | M | 11,980 | $6.55 | $78,469 | 281,323 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Nov 28, 2025 | Dec 2, 2025 | M | 3,750 | $7.80 | $29,250 | 285,073 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Nov 28, 2025 | Dec 2, 2025 | M | 94,384 | $12.14 | $1,145,822 | 379,457 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Nov 28, 2025 | Dec 2, 2025 | S | 162,820 | $19.50 | Sale −$3,174,990 | 216,637 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Nov 28, 2025 | Dec 2, 2025 | M · derivative | 11,980 | $6.55 | $78,469 | not reported | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Nov 28, 2025 | Dec 2, 2025 | M · derivative | 3,750 | $7.80 | $29,250 | not reported | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Nov 28, 2025 | Dec 2, 2025 | M · derivative | 94,384 | $12.14 | $1,145,822 | 8,581 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Dec 1, 2025 | Dec 1, 2025 | S | 124,998 | $18.94 | Sale −$2,367,462 | 2,709,241 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Nov 26, 2025 | Dec 1, 2025 | S | 35,736 | $19.68 | Sale −$703,284 | 2,834,239 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M | 834 | $6.27 | $5,229 | 297,625 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M | 20,834 | $6.55 | $136,463 | 318,459 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M | 49,480 | $6.55 | $324,094 | 367,939 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M | 34,375 | $7.27 | $249,906 | 402,314 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M | 119,809 | $12.14 | $1,454,481 | 522,123 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M | 83,145 | $3.99 | $331,749 | 605,268 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | S | 308,477 | $16.91 | Sale −$5,216,346 | 296,791 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M · derivative | 834 | $6.27 | $5,229 | not reported | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M · derivative | 20,834 | $6.55 | $136,463 | not reported | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M · derivative | 49,480 | $6.55 | $324,094 | not reported | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M · derivative | 34,375 | $7.27 | $249,906 | not reported | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M · derivative | 119,809 | $12.14 | $1,454,481 | 17,161 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 21, 2025 | Nov 24, 2025 | M · derivative | 83,145 | $3.99 | $331,749 | 116,404 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 20, 2025 | Nov 24, 2025 | M | 133,032 | $8.46 | $1,125,451 | 525,755 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 20, 2025 | Nov 24, 2025 | M | 68,961 | $12.14 | $837,187 | 594,716 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 20, 2025 | Nov 24, 2025 | S | 297,925 | $16.54 | Sale −$4,927,680 | 296,791 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 20, 2025 | Nov 24, 2025 | M · derivative | 133,032 | $8.46 | $1,125,451 | 66,517 | Yes | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Nov 20, 2025 | Nov 24, 2025 | M · derivative | 68,961 | $12.14 | $837,187 | 136,970 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Nov 17, 2025 | Nov 18, 2025 | S | 238 | $14.05 | Sale −$3,344 | 269,343 | No | Form 4 |
| Robins Chad MCEO and Chairman | Nov 12, 2025 | Nov 12, 2025 | S | 1,867 | $15.00 | Sale −$28,005 | 2,869,975 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Nov 11, 2025 | Nov 12, 2025 | S | 1,237 | $14.57 | Sale −$18,023 | 2,871,851 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Nov 10, 2025 | Nov 12, 2025 | S | 86,161 | $14.73 | Sale −$1,269,152 | 2,873,088 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Nov 10, 2025 | Nov 12, 2025 | S | 10,000 | $14.82 | Sale −$148,200 | 1,269,524 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | May 16, 2025 | May 20, 20254/A | S | 1,929 | $8.89 | Sale −$17,149 | 269,581 | No | Form 4/A |
| Piskel KyleChief Financial Officer | May 16, 2025 | May 19, 2025 | S | 1,929 | $8.89 | Sale −$17,149 | 277,396 | No | Form 4 |
| Piskel KyleChief Financial Officer | May 15, 2025 | May 19, 2025 | A | 7,815 | $0.00 | $0 | 279,325 | No | Form 4 |
| Robins Harlan SChief Scientific Officer | May 1, 2025 | May 5, 2025 | M | 68,412 | $6.32 | $432,364 | 1,347,936 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | May 1, 2025 | May 5, 2025 | S | 68,412 | $7.35 | Sale −$502,828 | 1,279,524 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | May 1, 2025 | May 5, 2025 | M · derivative | 68,412 | $6.32 | $432,364 | not reported | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 24, 2025 | Mar 26, 2025 | M | 1,698 | $6.32 | $10,731 | 1,281,222 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 24, 2025 | Mar 26, 2025 | S | 1,698 | $9.00 | Sale −$15,282 | 1,279,524 | Yes | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 24, 2025 | Mar 26, 2025 | M · derivative | 1,698 | $6.32 | $10,731 | 68,412 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Mar 14, 2025 | Mar 17, 2025 | M | 2,500 | $6.32 | $15,800 | 271,510 | No | Form 4 |
| Piskel KyleChief Financial Officer | Mar 14, 2025 | Mar 17, 2025 | M · derivative | 2,500 | $6.32 | $15,800 | not reported | No | Form 4 |
| Griffin Michelle Renee | Mar 13, 2025 | Mar 17, 2025 | S | 36,291 | $7.19 | Sale −$260,932 | 15,394 | No | Form 4 |
| Hershberg Robert | Mar 12, 2025 | Mar 12, 2025 | S | 53,000 | $7.59 | Sale −$402,270 | 69,690 | No | Form 4 |
| Neupert Peter M | Mar 10, 2025 | Mar 12, 2025 | M | 50,000 | $4.07 | $203,500 | 234,690 | No | Form 4 |
| Neupert Peter M | Mar 10, 2025 | Mar 12, 2025 | S | 10,000 | $7.05 | Sale −$70,500 | 224,690 | No | Form 4 |
| Neupert Peter M | Mar 10, 2025 | Mar 12, 2025 | M · derivative | 50,000 | $4.07 | $203,500 | not reported | No | Form 4 |
| Griffin Michelle Renee | Mar 6, 2025 | Mar 6, 2025 | S | 15,664 | $7.94 | Sale −$124,372 | 51,685 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Mar 6, 2025 | Mar 6, 2025 | S | 102,218 | $7.64 | Sale −$780,946 | 2,959,249 | No | Form 4 |
| Robins Chad MCEO and Chairman | Mar 5, 2025 | Mar 6, 2025 | S | 81,206 | $6.98 | Sale −$566,818 | 2,850,495 | No | Form 4 |
| Robins Chad MCEO and Chairman | Mar 5, 2025 | Mar 6, 2025 | S | 36,145 | $6.99 | Sale −$252,654 | 2,814,350 | No | Form 4 |
| Robins Chad MCEO and Chairman | Mar 5, 2025 | Mar 6, 2025 | A | 247,117 | $0.00 | $0 | 3,061,467 | No | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 5, 2025 | Mar 6, 2025 | S | 40,603 | $6.98 | Sale −$283,409 | 1,335,577 | No | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 5, 2025 | Mar 6, 2025 | S | 56,053 | $6.99 | Sale −$391,810 | 1,279,524 | No | Form 4 |
| Rubinstein JuliePresident and COO | Mar 5, 2025 | Mar 6, 2025 | S | 40,044 | $6.98 | Sale −$279,507 | 607,710 | No | Form 4 |
| Rubinstein JuliePresident and COO | Mar 5, 2025 | Mar 6, 2025 | S | 19,461 | $6.99 | Sale −$136,032 | 588,249 | No | Form 4 |
| Piskel KyleChief Financial Officer | Mar 5, 2025 | Mar 6, 2025 | S | 3,103 | $6.97 | Sale −$21,628 | 276,227 | No | Form 4 |
| Piskel KyleChief Financial Officer | Mar 5, 2025 | Mar 6, 2025 | S | 253 | $6.98 | Sale −$1,766 | 275,974 | No | Form 4 |
| Piskel KyleChief Financial Officer | Mar 5, 2025 | Mar 6, 2025 | S | 6,964 | $6.99 | Sale −$48,678 | 269,010 | No | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Mar 5, 2025 | Mar 6, 2025 | S | 41,600 | $6.98 | Sale −$290,368 | 395,788 | No | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Mar 5, 2025 | Mar 6, 2025 | S | 3,065 | $6.99 | Sale −$21,424 | 392,723 | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Mar 5, 2025 | Mar 6, 2025 | S | 26,023 | $6.98 | Sale −$181,641 | 347,238 | No | Form 4 |
| Lo FrancisChief People Officer | Mar 5, 2025 | Mar 6, 2025 | S | 7,085 | $6.98 | Sale −$49,453 | 346,636 | No | Form 4 |
| Lo FrancisChief People Officer | Mar 5, 2025 | Mar 6, 2025 | S | 13,790 | $6.99 | Sale −$96,392 | 332,846 | No | Form 4 |
| Griffin Michelle Renee | Mar 4, 2025 | Mar 6, 2025 | A | 15,394 | $0.00 | $0 | 67,349 | Yes | Form 4 |
| Griffin Michelle Renee | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 23,726 | $8.12 | $192,655 | 23,726 | Yes | Form 4 |
| Hershberg Robert | Mar 4, 2025 | Mar 6, 2025 | A | 15,394 | $0.00 | $0 | 122,690 | No | Form 4 |
| Hershberg Robert | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 23,726 | $8.12 | $192,655 | 23,726 | No | Form 4 |
| Neupert Peter M | Mar 4, 2025 | Mar 6, 2025 | A | 15,394 | $0.00 | $0 | 184,690 | No | Form 4 |
| Neupert Peter M | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 23,726 | $8.12 | $192,655 | 23,726 | No | Form 4 |
| Owen Katey Einterz | Mar 4, 2025 | Mar 6, 2025 | A | 15,394 | $0.00 | $0 | 72,629 | No | Form 4 |
| Owen Katey Einterz | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 23,726 | $8.12 | $192,655 | 23,726 | No | Form 4 |
| Pellini Michael J | Mar 4, 2025 | Mar 6, 2025 | A | 15,394 | $0.00 | $0 | 69,690 | No | Form 4 |
| Pellini Michael J | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 23,726 | $8.12 | $192,655 | 23,726 | No | Form 4 |
| Robins Chad MCEO and Chairman | Mar 4, 2025 | Mar 6, 2025 | A | 355,000 | $0.00 | $0 | 2,931,701 | No | Form 4 |
| Robins Harlan SChief Scientific Officer | Mar 4, 2025 | Mar 6, 2025 | A | 355,000 | $0.00 | $0 | 1,376,180 | No | Form 4 |
| Rubinstein JuliePresident and COO | Mar 4, 2025 | Mar 6, 2025 | A | 175,000 | $0.00 | $0 | 647,754 | No | Form 4 |
| Piskel KyleChief Financial Officer | Mar 4, 2025 | Mar 6, 2025 | A | 125,000 | $0.00 | $0 | 279,330 | No | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Mar 4, 2025 | Mar 6, 2025 | A | 109,973 | $0.00 | $0 | 437,388 | No | Form 4 |
| Benzeno SharonChief Commercial Ofc Imm Med | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 165,027 | $8.12 | $1,340,019 | 165,027 | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Mar 4, 2025 | Mar 6, 2025 | A | 119,971 | $0.00 | $0 | 373,261 | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 180,029 | $8.12 | $1,461,835 | 180,029 | No | Form 4 |
| Lo FrancisChief People Officer | Mar 4, 2025 | Mar 6, 2025 | A | 99,976 | $0.00 | $0 | 353,721 | No | Form 4 |
| Lo FrancisChief People Officer | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 150,024 | $8.12 | $1,218,195 | 150,024 | No | Form 4 |
| Robins Chad MCEO and Chairman | Feb 20, 2025 | Feb 21, 2025 | M | 99,107 | $6.32 | $626,356 | 2,675,808 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 20, 2025 | Feb 21, 2025 | S | 99,107 | $8.44 | Sale −$836,463 | 2,576,701 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 20, 2025 | Feb 21, 2025 | M · derivative | 99,107 | $6.32 | $626,356 | not reported | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 19, 2025 | Feb 21, 2025 | M | 186,080 | $6.32 | $1,176,026 | 2,762,781 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 19, 2025 | Feb 21, 2025 | S | 186,080 | $8.46 | Sale −$1,574,237 | 2,576,701 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 19, 2025 | Feb 21, 2025 | M · derivative | 186,080 | $6.32 | $1,176,026 | 99,107 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 18, 2025 | Feb 18, 2025 | M | 211,160 | $6.32 | $1,334,531 | 2,787,861 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 18, 2025 | Feb 18, 2025 | S | 211,160 | $8.50 | Sale −$1,794,860 | 2,576,701 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 18, 2025 | Feb 18, 2025 | M · derivative | 211,160 | $6.32 | $1,334,531 | 285,187 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 14, 2025 | Feb 18, 2025 | M | 158,921 | $6.32 | $1,004,381 | 2,735,622 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 14, 2025 | Feb 18, 2025 | S | 158,921 | $8.46 | Sale −$1,344,472 | 2,576,701 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 158,921 | $6.32 | $1,004,381 | 496,347 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 13, 2025 | Feb 18, 2025 | M | 100,287 | $6.32 | $633,814 | 2,676,988 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 13, 2025 | Feb 18, 2025 | S | 100,287 | $8.44 | Sale −$846,422 | 2,576,701 | Yes | Form 4 |
| Robins Chad MCEO and Chairman | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 100,287 | $6.32 | $633,814 | 655,268 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | Nov 18, 2024 | Nov 19, 2024 | S | 248 | $4.98 | Sale −$1,235 | 154,330 | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Oct 8, 2024 | Oct 10, 2024 | M | 5,000 | $1.98 | $9,900 | 253,290 | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Oct 8, 2024 | Oct 10, 2024 | M · derivative | 5,000 | $1.98 | $9,900 | not reported | No | Form 4 |
| Taylor Stacy LSVP and General Counsel | Aug 22, 2024 | Aug 23, 2024 | S | 26,922 | $4.50 | Sale −$121,149 | 139,365 | Yes | Form 4 |
| Piskel KyleChief Financial Officer | May 15, 2024 | May 17, 2024 | A | 31,260 | $0.00 | $0 | 154,578 | No | Form 4 |
| Neupert Peter M | Mar 12, 2024 | Mar 13, 2024 | M | 15,000 | $0.84 | $12,600 | 169,296 | No | Form 4 |
| Neupert Peter M | Mar 12, 2024 | Mar 13, 2024 | M · derivative | 15,000 | $0.84 | $12,600 | not reported | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Mar 5, 2024 | Mar 6, 2024 | S | 6,016 | $3.43 | Sale −$20,635 | 255,265 | No | Form 4 |
| Bobulsky SusanChief Commercial Officer, MRD | Mar 5, 2024 | Mar 6, 2024 | S | 6,975 | $3.44 | Sale −$23,994 | 248,290 | No | Form 4 |